MP-424(H), PEG-IFN-a-2b, RBV
G060-A5
Phase 1 small_molecule completed
Quick answer
MP-424(H), PEG-IFN-a-2b, RBV for Hepatitis C is a Phase 1 program (small_molecule) at Vertex Pharmaceuticals (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Vertex Pharmaceuticals (Ireland) Limited
- Indication
- Hepatitis C
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed